Cargando…
A new approach for COVID-19 treatment by micro-RNA
MicroRNAs (miRNAs) naturally occur in plants and all living organisms. They play an important role in gene regulation through binding toa specific region in open reading frames (ORFs) and/or untranslated regions (UTRs) to block the translation processes through either degrading or blocking mRNA resu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435294/ https://www.ncbi.nlm.nih.gov/pubmed/33017912 http://dx.doi.org/10.1016/j.mehy.2020.110203 |
_version_ | 1783572309694480384 |
---|---|
author | El-Nabi, Sobhy Hassab Elhiti, Mohamed El-Sheekh, Mostafa |
author_facet | El-Nabi, Sobhy Hassab Elhiti, Mohamed El-Sheekh, Mostafa |
author_sort | El-Nabi, Sobhy Hassab |
collection | PubMed |
description | MicroRNAs (miRNAs) naturally occur in plants and all living organisms. They play an important role in gene regulation through binding toa specific region in open reading frames (ORFs) and/or untranslated regions (UTRs) to block the translation processes through either degrading or blocking mRNA resulting in knocking down or suppression of targeted genes. Plants and many organisms protect themselves from viruses through the production of miRNAs, which are complementary to 3UTR of viruses resulting in degrading the viral mRNA or block the translation on ribosomes. As pandemic, COVID-19, and its consequences on the global economy, we hypothesized a new approach for the treatment of COVID-19 paints. This approach includes designing a mix of miRNAs targeting several regions on COVID-19 open reading frame (ORF) and 3 UTR and suitable delivery system targeting respiratory system tissues. These synthesized miRNAs may be delivered to humansinnon-viral delivery systems such as liposomes like exosome (extracellular vesicle), polymer-based carriers, or inorganic nanoparticles, which are considered to be more suitable for human use. |
format | Online Article Text |
id | pubmed-7435294 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74352942020-08-19 A new approach for COVID-19 treatment by micro-RNA El-Nabi, Sobhy Hassab Elhiti, Mohamed El-Sheekh, Mostafa Med Hypotheses Letter to Editors MicroRNAs (miRNAs) naturally occur in plants and all living organisms. They play an important role in gene regulation through binding toa specific region in open reading frames (ORFs) and/or untranslated regions (UTRs) to block the translation processes through either degrading or blocking mRNA resulting in knocking down or suppression of targeted genes. Plants and many organisms protect themselves from viruses through the production of miRNAs, which are complementary to 3UTR of viruses resulting in degrading the viral mRNA or block the translation on ribosomes. As pandemic, COVID-19, and its consequences on the global economy, we hypothesized a new approach for the treatment of COVID-19 paints. This approach includes designing a mix of miRNAs targeting several regions on COVID-19 open reading frame (ORF) and 3 UTR and suitable delivery system targeting respiratory system tissues. These synthesized miRNAs may be delivered to humansinnon-viral delivery systems such as liposomes like exosome (extracellular vesicle), polymer-based carriers, or inorganic nanoparticles, which are considered to be more suitable for human use. Elsevier Ltd. 2020-10 2020-08-19 /pmc/articles/PMC7435294/ /pubmed/33017912 http://dx.doi.org/10.1016/j.mehy.2020.110203 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to Editors El-Nabi, Sobhy Hassab Elhiti, Mohamed El-Sheekh, Mostafa A new approach for COVID-19 treatment by micro-RNA |
title | A new approach for COVID-19 treatment by micro-RNA |
title_full | A new approach for COVID-19 treatment by micro-RNA |
title_fullStr | A new approach for COVID-19 treatment by micro-RNA |
title_full_unstemmed | A new approach for COVID-19 treatment by micro-RNA |
title_short | A new approach for COVID-19 treatment by micro-RNA |
title_sort | new approach for covid-19 treatment by micro-rna |
topic | Letter to Editors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435294/ https://www.ncbi.nlm.nih.gov/pubmed/33017912 http://dx.doi.org/10.1016/j.mehy.2020.110203 |
work_keys_str_mv | AT elnabisobhyhassab anewapproachforcovid19treatmentbymicrorna AT elhitimohamed anewapproachforcovid19treatmentbymicrorna AT elsheekhmostafa anewapproachforcovid19treatmentbymicrorna AT elnabisobhyhassab newapproachforcovid19treatmentbymicrorna AT elhitimohamed newapproachforcovid19treatmentbymicrorna AT elsheekhmostafa newapproachforcovid19treatmentbymicrorna |